Larvol Delta - Safety-and-Efficacy-of-Combining-APL101-With-Frontline-Osimertinib-in-Patients-With-EGFRmutated-Metastatic-Nonsmall-Cell-Lung-Cancer-NSCLC

Tagrisso (osimertinib) - AstraZeneca

bozitinib (APL-101) - Apollomics

simmitinib (SYHA1817) - CSPC Pharma

http://clinicaltrials.gov/ct2/show/NCT04743505

Jan 21, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next